Vimian acquires UK allergy business

March 16, 2022

The Vimian Group is a global and fast-growing group of innovation-driven companies that share a passion for making a positive impact through improving animal health.

Vimian Group’s Specialty Pharma segment Nextmune has acquired the veterinary allergy division, Avacta Animal Health, from AvactaGroup plc. Avacta Animal Health provides veterinary allergy diagnostic solutions through its laboratory in Wetherby (UK) and re-sells Nextmune’s immunotherapy products to veterinary clinics across the UK. The business division also provides testing kits to veterinary laboratories in other European countries. The acquisition is a carve-out from AvactaGroup plc, a UK-based company focused on diagnostic solutions for human health.

The business had revenues of GBP 1.6 million in 2021.

Read more here.

Recent news

US expansion continues for Odevo – William …

Odevo, an international leader that is driving change in the traditional property management industry, continues its rapid expansion in the US market with the addition of the leading property manager in the Carolinas, William Douglas Management. William Douglas manages over

Read more

Fidelio raises a record EUR 1bn+ for its new inve…

Fidelio Capital (“Fidelio”) marks a significant milestone with the successful closing of its latest investment mandate (“Fidelio III”), with total capital commitments in excess of the EUR 1 billion target, which is more than triple the size of its previous

Read more

iBinder Group acquires REQS System

REQS System AB now becomes part of the iBinder Group and strengthens the group’s offering in property management, inspections, and controlling. The acquisition is an important step in iBinder’s goal of creating a simple platform for the property’s entire life

Read more